Vericel Corp (VCEL)

• Market cap: $2.57B
• 1 day: -4.25%
• 5 days: -8.87%
• 1 month: -12.69%
• 3 months: -8.31%
• 6 months: 8.13%
• Year to date: -5.64%
• 1 year: 8.04%
• 5 years: 170.55%
• 10 years: 1,877.19%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

200% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 3 (+2) [Q4]

41% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 29

32% more capital invested

Capital invested by funds: $2.17B [Q3] → $2.86B (+$695M) [Q4]

17% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 84

2% more funds holding

Funds holding: 263 [Q3] → 269 (+6) [Q4]

0.2% more ownership

Funds ownership: 105.4% [Q3] → 105.6% (+0.2%) [Q4]

16% less call options, than puts

Call options by funds: $6.28M | Put options by funds: $7.49M

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $60 15% upside
• Avg. target: $65 25% upside
• High target: $67 29% upside

5 analyst ratings

• positive: 5 100%
• neutral: 0 0%
• negative: 0 0%

Canaccord Genuity Caitlin Cronin 67% 1-year accuracy 8 / 12 met price target	29% upside $67	Buy Maintained	3 Feb 2025
Stephens & Co. Mason Carrico 40% 1-year accuracy 8 / 20 met price target	25% upside $65	Overweight Reiterated	15 Jan 2025
HC Wainwright & Co. Swayampakula Ramakanth 38% 1-year accuracy 74 / 194 met price target	15% upside $60	Buy Reiterated	15 Jan 2025
Truist Securities Samuel Brodovsky 92% 1-year accuracy 11 / 12 met price target	29% upside $67	Buy Maintained	18 Dec 2024
BTIG Ryan Zimmerman 70% 1-year accuracy 33 / 47 met price target	27% upside $66	Buy Maintained	26 Nov 2024